MASSDEVICE ON CALL — Big pharma logged two important wins in the nation’s highest court yesterday, freeing prescription data for commercial sale and limiting lawsuits filed by people harmed by generic drugs.

The U.S. Supreme Court overturned a Vermont law banning "detailing" of prescription information collected by pharmacies, allowing drug companies to mine prescriber-identifiable prescription info to target marketing toward physicians based on the kinds of medicine they tend to prescribe.

The court ruled 6 to 3 in favor of the drug companies.